Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Risk of relapse and patient selection for metastatic colorectal cancer liver surgery.
Authors
Madalena Machete
Hospital Beatriz Angelo, Loures, Portugal
Madalena Machete , Pedro Azevedo , Francisco Lopes , Carlota Baptista , Inês Margarido , Carlota Branco , Jorge Correia , João Moreira Pinto , José António Pereira , Pedro Simões , Ana Faria Harrison , Tânia Abreu Rodrigues , Jose N. Teixeira , Jose Luis P. Coelho
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 96)
DOI
10.1200/JCO.2024.42.3_suppl.96
Abstract #
96
Poster Bd #
F19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
First Author: Romain Cohen
Poster
2018 ASCO Annual Meeting
Outcomes of oxaliplatin-based (Ox) chemotherapy (CT) on R0 resection of colonic liver metastases (CLM).
First Author: Nicholas Adam Bosma
Poster
2017 Gastrointestinal Cancers Symposium
Impact of clinical and molecular features on risk of recurrence following curative intent resection of metastases in metastatic colorectal cancer.
First Author: Matthew E. Burge
Poster
2016 ASCO Annual Meeting
Bevacizumab plus chemotherapy (bev/CT) as first-line therapy for patients with potentially resectable metastatic colorectal cancer (mCRC): Final results of the French noninterventional PICASSO study.
First Author: David Malka